There is no requirement that a clinical trial be entirely concluded before approval can be granted. Once the data is sufficient to establish safety and effectiveness, the applicant may apply for full authorization or emergency use authorization in the United States.
There is no reason to stop the trial early just because authorization or EUA has been attained.